Published in Medical Device Business Week, February 9th, 2005
The agreements are subject to customary closing conditions.
Rodman & Renshaw, LLC served as placement agent in this transaction. The shares are offered through a prospectus supplement pursuant to the company's effective shelf registration statement previously filed with the Securities and Exchange Commission.
Alteon intends to use the net proceeds from the sale...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.